HEARTSCIENCES INC (HSCS) Fundamental Analysis & Valuation

NASDAQ:HSCS • US42254E3027

Current stock price

2.05 USD
+0.01 (+0.49%)
Last:

This HSCS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. HSCS Profitability Analysis

1.1 Basic Checks

  • HSCS had negative earnings in the past year.
  • HSCS had a negative operating cash flow in the past year.
  • HSCS had negative earnings in each of the past 5 years.
  • In the past 5 years HSCS always reported negative operating cash flow.
HSCS Yearly Net Income VS EBIT VS OCF VS FCFHSCS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 -2M -4M -6M -8M

1.2 Ratios

  • HSCS has a worse Return On Assets (-112.32%) than 83.42% of its industry peers.
  • HSCS's Return On Equity of -319.95% is on the low side compared to the rest of the industry. HSCS is outperformed by 82.35% of its industry peers.
Industry RankSector Rank
ROA -112.32%
ROE -319.95%
ROIC N/A
ROA(3y)-156.79%
ROA(5y)-165.73%
ROE(3y)-2372.45%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HSCS Yearly ROA, ROE, ROICHSCS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 0 -1K -2K -3K -4K

1.3 Margins

  • HSCS has a Gross Margin (57.47%) which is comparable to the rest of the industry.
  • HSCS's Gross Margin has improved in the last couple of years.
  • HSCS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 57.47%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.97%
GM growth 5Y15.56%
HSCS Yearly Profit, Operating, Gross MarginsHSCS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 -50K -100K -150K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. HSCS Health Analysis

2.1 Basic Checks

  • HSCS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, HSCS has more shares outstanding
  • Compared to 5 years ago, HSCS has less shares outstanding
  • HSCS has a worse debt/assets ratio than last year.
HSCS Yearly Shares OutstandingHSCS Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M
HSCS Yearly Total Debt VS Total AssetsHSCS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M

2.2 Solvency

  • Based on the Altman-Z score of -17.77, we must say that HSCS is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of HSCS (-17.77) is worse than 88.24% of its industry peers.
  • HSCS has a Debt/Equity ratio of 0.16. This is a healthy value indicating a solid balance between debt and equity.
  • With a Debt to Equity ratio value of 0.16, HSCS perfoms like the industry average, outperforming 59.36% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Altman-Z -17.77
ROIC/WACCN/A
WACC8.03%
HSCS Yearly LT Debt VS Equity VS FCFHSCS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 5M -5M

2.3 Liquidity

  • HSCS has a Current Ratio of 1.19. This is a normal value and indicates that HSCS is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of HSCS (1.19) is worse than 87.17% of its industry peers.
  • A Quick Ratio of 1.04 indicates that HSCS should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.04, HSCS is doing worse than 81.28% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.19
Quick Ratio 1.04
HSCS Yearly Current Assets VS Current LiabilitesHSCS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 2M 4M 6M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. HSCS Growth Analysis

3.1 Past

  • HSCS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 81.21%, which is quite impressive.
  • The Revenue for HSCS has decreased by -76.34% in the past year. This is quite bad
  • Measured over the past years, HSCS shows a very negative growth in Revenue. The Revenue has been decreasing by -41.50% on average per year.
EPS 1Y (TTM)81.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.49%
Revenue 1Y (TTM)-76.34%
Revenue growth 3Y-32.65%
Revenue growth 5Y-41.5%
Sales Q2Q%N/A

3.2 Future

  • HSCS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.72% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y62.51%
EPS Next 2Y29.28%
EPS Next 3Y20.72%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HSCS Yearly Revenue VS EstimatesHSCS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2027 2028 1M 2M 3M
HSCS Yearly EPS VS EstimatesHSCS Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 -20 -40 -60

More info and screens

Find the best growth stocksShow best growing peers

1

4. HSCS Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for HSCS. In the last year negative earnings were reported.
  • Also next year HSCS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HSCS Price Earnings VS Forward Price EarningsHSCS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HSCS Per share dataHSCS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3 -4

4.3 Compensation for Growth

  • HSCS's earnings are expected to grow with 20.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.28%
EPS Next 3Y20.72%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. HSCS Dividend Analysis

5.1 Amount

  • No dividends for HSCS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

HSCS Fundamentals: All Metrics, Ratios and Statistics

HEARTSCIENCES INC

NASDAQ:HSCS (4/24/2026, 4:36:37 PM)

2.05

+0.01 (+0.49%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-16
Earnings (Next)N/A
Inst Owners6.21%
Inst Owner Change0%
Ins Owners2.34%
Ins Owner Change75.21%
Market Cap6.52M
Revenue(TTM)8.70K
Net Income(TTM)-8.49M
Analysts82.5
Price Target10.2 (397.56%)
Short Float %1.13%
Short Ratio2.82
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)42.57%
Min EPS beat(2)27.34%
Max EPS beat(2)57.81%
EPS beat(4)4
Avg EPS beat(4)30.42%
Min EPS beat(4)18.08%
Max EPS beat(4)57.81%
EPS beat(8)5
Avg EPS beat(8)-38.51%
EPS beat(12)7
Avg EPS beat(12)-25.63%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.66%
PT rev (3m)-5.66%
EPS NQ rev (1m)10.98%
EPS NQ rev (3m)6.41%
EPS NY rev (1m)7.77%
EPS NY rev (3m)45.74%
Revenue NQ rev (1m)-100%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-100%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 749.31
P/FCF N/A
P/OCF N/A
P/B 2.46
P/tB 12.12
EV/EBITDA N/A
EPS(TTM)-4.94
EYN/A
EPS(NY)-3.08
Fwd EYN/A
FCF(TTM)-2.32
FCFYN/A
OCF(TTM)-2.31
OCFYN/A
SpS0
BVpS0.83
TBVpS0.17
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -112.32%
ROE -319.95%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 57.47%
FCFM N/A
ROA(3y)-156.79%
ROA(5y)-165.73%
ROE(3y)-2372.45%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.97%
GM growth 5Y15.56%
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 183.51%
Cap/Sales 601.15%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.19
Quick Ratio 1.04
Altman-Z -17.77
F-Score3
WACC8.03%
ROIC/WACCN/A
Cap/Depr(3y)199.15%
Cap/Depr(5y)121.34%
Cap/Sales(3y)570.65%
Cap/Sales(5y)345.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)81.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.49%
EPS Next Y62.51%
EPS Next 2Y29.28%
EPS Next 3Y20.72%
EPS Next 5YN/A
Revenue 1Y (TTM)-76.34%
Revenue growth 3Y-32.65%
Revenue growth 5Y-41.5%
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-32.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year15.08%
EBIT Next 3Y-0.48%
EBIT Next 5YN/A
FCF growth 1Y-15.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-14.78%
OCF growth 3YN/A
OCF growth 5YN/A

HEARTSCIENCES INC / HSCS Fundamental Analysis FAQ

What is the fundamental rating for HSCS stock?

ChartMill assigns a fundamental rating of 1 / 10 to HSCS.


Can you provide the valuation status for HEARTSCIENCES INC?

ChartMill assigns a valuation rating of 1 / 10 to HEARTSCIENCES INC (HSCS). This can be considered as Overvalued.


How profitable is HEARTSCIENCES INC (HSCS) stock?

HEARTSCIENCES INC (HSCS) has a profitability rating of 1 / 10.


What is the financial health of HEARTSCIENCES INC (HSCS) stock?

The financial health rating of HEARTSCIENCES INC (HSCS) is 2 / 10.